NJ Top Docs 2022, Dr, Brian Mehling and Dr. Pavel Yufit Specialize in Trauma Treatment

NJ Top Docs has reviewed and approved board-certified orthopedic surgeons, Brian Mehling, MD and Pavel Yufit, MD of Mehling Orthopedics for 2022. Both are fellows of the American Academy of Orthopedic Surgeons and specialize in trauma treatment. They are also members of the Orthopaedic Trauma Association.

Their practice, Mehling Orthopedics is an orthopedic trauma practice dedicated to creating individualized treatment plans for traumatic injuries and disabilities.

Dr. Mehling started his path in medicine through undergraduate study at Harvard University, obtaining his Bachelor of Arts and Master of Science degrees in Biochemistry from Ohio State University.

Completing his degree of medicine at Wright State University School of Medicine, Dr. Mehling received post graduate education through residencies and fellowships at St. Joseph’s Hospital in Paterson, NJ and the Graduate Hospital in Philadelphia, PA, while pursuing a Ph.D. in Chemistry (which he is currently completing at Seton Hall University).

Dr. Mehling operates practices in northern New Jersey and Long Island, New York where he is on staff at Good Samaritan Hospital, Hackensack University Medical Center, Hackensack University Medical Center at Pascack Valley, Hackensack Meridian Palisades Medical Center, Hudson Regional Hospital, St. Joseph’s Medical Center, and St. Joseph’s Wayne Medical Center.

Dr. Yufit is fluent in Russian as well as English. He is involved with orthopedic research and participates in hospital-based orthopedic trauma studies to create better-individualized care plans that improve patient outcomes during treatment.

Dr. Yufit’s medical education began at the New York University School of Medicine. He then went on to complete his orthopedic surgery residency at New York Medical College at St. Vincent’s Hospital in the Manhattan, Brooklyn, Queens boroughs of New York City. After finishing his residency, Dr. Yufit was accepted into a competitive orthopedic trauma fellowship program at the University of Louisville in Louisville, Kentucky.

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit www.NJTopDocs.com.You can also follow us on Facebook, Twitter, & Instagram.


ZURICH, Switzerland – May 4, 2022 – Brian Mehling, MD, a world-renowned stem cell researcher, board-certified orthopedic trauma surgeon, board-certified in anti-aging medicine, and founder of Blue Horizon International (BHI), will be attending the Annual World Economic Forum (WEF) in Davos from May 22-26. This will be Dr. Mehling’s ninth year attending the global conference.

The 52nd Annual Meeting will convene on the theme “Working Together, Restoring Trust,” with the aim to address economic, environmental, political and social fault-lines exacerbated by the COVID-19 pandemic.
Dr. Mehling and his team will be available onsite to share insights on the current and upcoming breakthroughs within the stem cells arena, as pertinent to the technology revolution and the future of the world.

“Stem cell therapies are, without a doubt, the future of medicine. I believe they will become the preferred substitutes for many surgical, pharmacological, and rehabilitative medical services,” shared Dr. Brian Mehling, Founder of Blue Horizon International. “The importance of research and the key direction that it will take will truly shape the way patients with chronic conditions, disorders, and acute diseases are treated.”

WEF began as a forum to generate ideas and solutions to help shape the global, regional, and industry agendas. The event attracts top-level business leaders from all over the world. Attendees include C-suite executives from corporations, heads of state and government, leaders of international organizations, civil society and religious organizations, academia, the media, and the arts.

Onsite interviews with Dr. Mehling at WEF will be available upon request and handled on a first-come, first-serve basis. To learn more about WEF, please visit: http://www.weforum.org

About Blue Horizon International
Blue Horizon International is a healthcare consulting company with a unique mission that combines treatment, research, and philanthropic efforts. Across the globe quality care and services for medical treatments are provided along with resources needed to assist children and adults who are medically underserved. For more information, please visit Blue Horizon International at www.bluehorizoninternational.com.
Media contact: knovakova@bluehorizoninternational.com